Universal Health Services/$UHS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Universal Health Services

Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.

Ticker

$UHS

Primary listing

NYSE

Industry

Health Care Providers & Services

Employees

87,500

ISIN

US9139031002
Website

UHS Metrics

BasicAdvanced
$12B
10.26
$17.80
1.29
$0.80
0.44%

What the Analysts think about UHS

Analyst ratings (Buy, Hold, Sell) for Universal Health Services stock.

Bulls say / Bears say

Universal Health Services (UHS) reported a 6.7% increase in revenue to $4.10 billion for Q1 2025, surpassing analyst expectations and indicating strong operational performance. (TradingView News)
The company authorized a $1 billion increase to its stock repurchase program in July 2024, demonstrating confidence in its financial health and commitment to returning value to shareholders. (Nasdaq)
UHS raised its full-year 2024 revenue forecast to between $15.565 billion and $15.753 billion, reflecting optimism about future growth prospects. (Markets Insider)
In Q3 2024, UHS faced higher expenses that negatively impacted its profit margins, raising concerns about cost management. (Webull)
Wells Fargo & Company lowered its price target for UHS to $230.00 in November 2024, suggesting potential challenges in meeting growth expectations. (Defense World)
Assetmark Inc. sold 7,207 shares of UHS in March 2025, indicating possible reduced confidence among institutional investors. (MarketBeat)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.

UHS Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

UHS Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $UHS

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs